BridgeMD
New treatment option for Cervical Cancer
Official title Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr
ClinicalTrials.gov ID: NCT05421650
What this study is testing
- What it's testing
- This study is a prospective, multicenter and randomized clinical trial (DEBULK trial) to determine the therapeutic effect of surgical debulking of bulky or multiple lymph nodes before concurrent chemoradiation therapy (CCRT) in cervical cancer stage IIICr.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70, women only
You may be able to join if
- 1) (1) Women aged ≥ 20 years and ≤ 70 years (2) Patients newly diagnosed with squamous cell carcinoma (SCC), adenocarcinoma, or adenosquamous...
You likely can't join if
- (1) Patients who have been diagnosed with cancer of any organ other than thyroid cancer (excluding stage 0 cancer) within the previous 5 years (2)...
The study team makes the final eligibility decision.
Where it's taking place
- Bengaluru, India
- Rome, Italy
- Târgu Mureş, Romania
- Cheonan, Chungcheongnam-do, South Korea
- Ansan-si, Gyeonggi-do, South Korea
- Goyang-si, Gyeonggi-do, South Korea
- Seongnam-si, Gyeonggi-do, South Korea
- Yangsan, Gyeongsangbuk-do, South Korea
- Changwon, Gyeongsangnam-do, South Korea
- Hwasun, Jeollanam-do, South Korea
- Busan, South Korea
- Daegu, South Korea
- Incheon, South Korea
- Seoul, South Korea
- Ho Chi Minh City, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bengaluru, India; Rome, Italy; Târgu Mureş, Romania; Cheonan, Chungcheongnam-do, South Korea; Ansan-si, Gyeonggi-do, South Korea; Goyang-si, Gyeonggi-do, South Korea and 9 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.